News

VIDEO: CT and 3D-echo imaging boost TAVR performance


 

AT EUROECHO-IMAGING 2014

References

VIENNA – Transcatheter aortic valve replacement has benefited enormously from the recent introduction of CT and three-dimensional echocardiography imaging into routine preprocedural planning and periprocedural guidance.

These two imaging methods have allowed clinicians to better select the right valve size for each patient, and 3D echo performed during transcatheter aortic valve replacement (TAVR) has also refined valve placement. The result has been TAVR procedures that go faster and have more accurate results while producing fewer complications, Dr. Rebecca Hahn said during an interview at the annual meeting of the European Association of Cardiovascular Imaging.

Perhaps the biggest impact of better valve-size selection and more detailed procedural guidance has been a reduced incidence and severity of paravalvular regurgitation once TAVR is complete and the replacement valve deployed. In recent months, Dr. Hahn and her associates at Columbia University Medical Center in New York have had no patients develop moderate or severe paravalvular regurgitation following TAVR, and the incidence of mild paravalvular leaks has dropped by about half, compared with when the procedure was first performed about 5 years ago, said Dr. Hahn, director of invasive and valvular echocardiography at Columbia.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

mzoler@frontlinemedcom.com

On Twitter@mitchelzoler

Recommended Reading

Imaging procedure costs higher in the United States
MDedge Internal Medicine
Radiation exposure in children with heart disease highest for transplants
MDedge Internal Medicine
Psychiatric comorbidities add to migraineurs’ medical interventions
MDedge Internal Medicine
USPSTF: Women smokers might benefit from AAA screening
MDedge Internal Medicine
First appropriate use criteria for transthoracic echocardiography released for suspected pediatric heart disease
MDedge Internal Medicine
FDA finalizes medical device cybersecurity guidance
MDedge Internal Medicine
Nonobstructive CAD increases risk of MI and death
MDedge Internal Medicine
Annual echo an option for cardiac allograft vasculopathy screening
MDedge Internal Medicine
Ultrasound plus transthoracic echocardiography speeds CVC placement
MDedge Internal Medicine
FDA clears noninvasive method of obtaining FFR measurements
MDedge Internal Medicine

Related Articles